Back to Oregon

SB707 • 2025

Expands the exemption for receipts from the sale of prescription drugs from commercial activity subject to the corporate activity tax to include critical access pharmacies.

Expands the exemption for receipts from the sale of prescription drugs from commercial activity subject to the corporate activity tax to include critical access pharmacies.

Taxes
Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Senator Meek, Senator Bonham,, McLane,, Nash,, Smith DB,, Representative Diehl,, Elmer,, Gomberg,, Mannix,, Nguyen D,, Osborne,, Scharf,, Wright,
Last action
2025-06-27
Official status
In Senate Committee
Effective date
Not listed

Plain English Breakdown

The plain English breakdown is still being put together. The official documents below are already here.

Bill History

  1. 2025-06-27 Senate

    In committee upon adjournment.

  2. 2025-03-05 Senate

    Public Hearing held.

  3. 2025-01-17 Senate

    Referred to Finance and Revenue.

  4. 2025-01-13 Senate

    Introduction and first reading. Referred to President's desk.

Official Summary Text

Digest: The Act makes certain rural pharmacy drug sale receipts not taxed by the CAT. (Flesch Readability Score: 77.8).
Expands the exemption for receipts from the sale of prescription drugs from commercial activity subject to the corporate activity tax to include critical access pharmacies. Applies to tax years beginning on or after January 1, 2026.
Takes effect on the 91st day following adjournment sine die.
Relating to: Relating to exemption of prescription drug sales; prescribing an effective date.
Current location: In Senate Committee